drugset / Trial / NCT03183570

Detection of Integrin avb6 in IPF, PSC, and COVID19 Using PET/CT

NCT03183570 ↗

Non-randomizedSingle-groupOpen-labelDiagnostic

Summary

Detection of Integrin avb6 in Idiopathic Pulmonary Fibrosis, Primary Sclerosing Cholangitis, and Coronavirus Disease 2019 with \[18F\]FP-R01-MG-F2 with PET/CT

Timeline

Start
2017-11-08
Primary completion
2023-04-25
Completion
2025-01-25

Drugs

EvaluationDrugModalityDoseRoute
Subject [18F]FP-R01-MG-F2 Peptide 259 mbq —